Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Teva Pharmaceutical Industries Ltd patents (2016 archive)


Recent patent applications related to Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd is listed as an Agent/Assignee. Note: Teva Pharmaceutical Industries Ltd may have other listings under different names/spellings. We're not affiliated with Teva Pharmaceutical Industries Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Teva Pharmaceutical Industries Ltd-related inventors


Treatment of multiple sclerosis by alemtuzumab induction followed by laquinimod therapy

This invention provides a method of treating a subject afflicted with multiple sclerosis (ms) or presenting clinically isolated syndrome (cis) which comprises a) administering to the subject an amount of an anti-cd52 antibody, followed by b) periodically administering to the subject an amount of laquinimod. This invention also provides packages comprising pharmaceutical compositions of laquinimod or an anti-cd52 antibody for treating such a subject wherein laquinimod is to be administered as a maintenance therapy in such a subject who has received an anti-cd52 antibody induction therapy.. ... Teva Pharmaceutical Industries Ltd

Formulations of 6-mercaptopurine

The present invention provides improved formulations of 6-mercaptopurine that exhibit better bioavailability and faster dissolution than previous formulations.. . ... Teva Pharmaceutical Industries Ltd

Gene expression biomarkers of laquinimod responsiveness

This invention provides a method of predicting clinical responsiveness to laquinimod therapy in a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising evaluating expression of a biomarker in the subject. This invention also provides a method of treating said subject comprising determining whether the subject is a laquinimod-responder by evaluating expression of a biomarker. ... Teva Pharmaceutical Industries Ltd

Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir

The present invention relates to an oral unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir and their use to treat hiv infection.. . ... Teva Pharmaceutical Industries Ltd

Treatment of neurodegenerative diseases with combination of laquinimod and fingolimod

This invention provides a method of treating a subject afflicted with a neurodegenerative disease comprising periodic administration of an amount of laquinimod and an amount of fingolimod, wherein the amounts when taken together are effective to treat the subject. Also provided are packages and pharmaceutical compositions comprising laquinimod and fingolimod for treating a subject afflicted with a neurodegenerative disease. ... Teva Pharmaceutical Industries Ltd

Crystals of laquinimod sodium and improved process for the manufacture thereof

The subject invention provides a mixture of crystalline laquinimod sodium particles, wherein (i) ≧90% of the total amount by volume of the laquinimod sodium particles have a size of ≦40 μm or (ii) ≧50% of the total amount by volume of the laquinimod sodium particles have a size of ≦15 μm and wherein: a) the mixture has a bulk density of 0.2-0.4 g/ml; b) the mixture has a tapped density of 0.40-0.7 g/ml; c) an amount of heavy metal in the mixture is no more than 20 ppm relative to the amount by weight of laquinimod sodium; d) an amount of mcq in the mixture is no more than 0.15% relative to the amount of laquinimod sodium as measured by hplc; e) an amount of mcqca in the mixture is no more than 0.15% relative to the amount of laquinimod sodium as measured by hplc; or f) an amount of mcqme in the mixture is no more than 0.12% relative to the amount of laquinimod sodium as measured by hplc. The subject invention also provides a pharmaceutical composition comprising an amount of laquinimod and at least one of bh-3-hkaq, mcq, mcqca, mcqme, nea, and mcqee. ... Teva Pharmaceutical Industries Ltd

Transdermal formulations of laquinimod

This invention provides a transdermal patch comprising a) a backing layer; b) a liner; c) optionally, a highly porous membrane; and d) a pharmaceutical composition comprising: (i) optionally, a pressure sensitive adhesive in an amount of up to about 95 wt % of the pharmaceutical composition, (ii) laquinimod in an amount of about 0.1-20 wt % of the pharmaceutical composition, and (iii) optionally, one or more permeation enhancers in a total amount of up to about 70 wt % of the pharmaceutical composition. This invention also provides a method for delivering laquinimod across the skin of the subject and for treating a human subject afflicted with a form of multiple sclerosis comprising administering to the skin of the subject a transdermal patch as described herein. ... Teva Pharmaceutical Industries Ltd

Rituximab induction therapy followed by glatiramer acetate therapy

The present invention provides a method of treating a subject afflicted with a form of multiple sclerosis or presenting a clinically isolated syndrome comprising periodic administration of an amount of an anti-cd20 antibody at least twice to the subject followed by periodic administration of an amount of glatiramer acetate to the subject, wherein the amounts are effective to treat the subject.. . ... Teva Pharmaceutical Industries Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Teva Pharmaceutical Industries Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Teva Pharmaceutical Industries Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###